Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress

Cell

Volumn 142, Issue 4, 2010, Pages 613-624

  Seifert, Ulrike ^a   Bialy, Lukasz P ^a,c   Ebstein, Frédéric ^a   Bech Otschir, Dawadschargal ^a   Voigt, Antje ^a   Schröter, Friederike ^a   Prozorovski, Timour ^b   Lange, Nicole ^a   Steffen, Janos ^a   Rieger, Melanie ^a   Kuckelkorn, Ulrike ^a   Aktas, Orhan ^b   Kloetzel, Peter M ^a   Krüger, Elke ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cellbio; Cellimmuno

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; IMMUNOPROTEASOME; PROTEASOME; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONJUGATION; CONTROLLED STUDY; HOMEOSTASIS; IMMUNOPRECIPITATION; INTERFERON INDUCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; UBIQUITINATION; UPREGULATION;

MURINAE;

EID: 77955596988     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.07.036     Document Type: Article

References (49)

1. Aki M., Shimbara N., Takashina M., Akiyama K., Kagawa S., Tamura T., Tanahashi N., Yoshimura T., Tanaka K., Ichihara A. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 1994, 115:257-269.
2. Bech-Otschir D., Helfrich A., Enenkel C., Consiglieri G., Seeger M., Holzhütter H.G., Dahlmann B., Kloetzel P.M. Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome. Nat. Struct. Mol. Biol. 2009, 16:219-225.
3. Bose S., Brooks P., Mason G.G., Rivett A.J. Gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. Biochem. J. 2001, 353:291-297.
4. Callahan M.K., Wohlfert E.A., Ménoret A., Srivastava P.K. Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes. J. Immunol. 2006, 177:8393-8399.
5. Chen W., Norbury C.C., Cho Y., Yewdell J.W., Bennink J.R. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 2001, 193:1319-1326.
6. Chou B., Hisaeda H., Shen J., Duan X., Imai T., Tu L., Murata S., Tanaka K., Himeno K. Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein. Microbes Infect. 2008, 10:241-250.
7. Dantuma N.P., Groothuis T.A., Salomons F.A., Neefjes J. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J. Cell Biol. 2006, 173:19-26.
8. Deol P., Zaiss D.M., Monaco J.J., Sijts A.J. Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes. J. Immunol. 2007, 178:7557-7562.
9. Díaz-Hernández M., Hernández F., Martín-Aparicio E., Gómez-Ramos P., Morán M.A., Castaño J.G., Ferrer I., Avila J., Lucas J.J. Neuronal induction of the immunoproteasome in Huntington's disease. J. Neurosci. 2003, 23:11653-11661.
10. Ebstein F., Lange N., Urban S., Seifert U., Krüger E., Kloetzel P.M. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 2009, 41:1205-1215.
11. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., Engemann S., Pastore A., Wanker E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15:558-566.
12. Ferrer I., Boada Rovira M., Sánchez Guerra M.L., Rey M.J., Costa-Jussá F. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol. 2004, 14:11-20.
13. Gaczynska M., Rock K.L., Goldberg A.L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993, 365:264-267.
14. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 2003, 426:895-899.
15. Griffin T.A., Nandi D., Cruz M., Fehling H.J., Kaer L.V., Monaco J.J., Colbert R.A. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 1998, 187:97-104.
16. Heink S., Ludwig D., Kloetzel P.M., Krüger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. USA 2005, 102:9241-9246.
17. Ishii K., Hisaeda H., Duan X., Imai T., Sakai T., Fehling H.J., Murata S., Chiba T., Tanaka K., Hamano S., et al. The involvement of immunoproteasomes in induction of MHC class I-restricted immunity targeting Toxoplasma SAG1. Microbes Infect. 2006, 8:1045-1053.
18. Kaur S., Sassano A., Dolniak B., Joshi S., Majchrzak-Kita B., Baker D.P., Hay N., Fish E.N., Platanias L.C. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 2008, 105:4808-4813.
19. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2001, 2:179-187.
20. Kloetzel P.M., Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 2004, 16:76-81.
21. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10:524-530.
22. Kotamraju S., Matalon S., Matsunaga T., Shang T., Hickman-Davis J.M., Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic. Biol. Med. 2006, 40:1034-1044.
23. Krüger E., Kuckelkorn U., Sijts A., Kloetzel P.M. The components of the proteasome system and their role in MHC class I antigen processing. Rev. Physiol. Biochem. Pharmacol. 2003, 148:81-104.
24. Lelouard H., Ferrand V., Marguet D., Bania J., Camosseto V., David A., Gatti E., Pierre P. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J. Cell Biol. 2004, 164:667-675.
25. Lelouard H., Schmidt E.K., Camosseto V., Clavarino G., Ceppi M., Hsu H.T., Pierre P. Regulation of translation is required for dendritic cell function and survival during activation. J. Cell Biol. 2007, 179:1427-1439.
26. Liu Y.C., Penninger J., Karin M. Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 2005, 5:941-952.
27. Medicherla B., Goldberg A.L. Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J. Cell Biol. 2008, 182:663-673.
28. Mukhopadhyay D., Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007, 315:201-205.
29. Nussbaum A.K., Rodriguez-Carreno M.P., Benning N., Botten J., Whitton J.L. Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J. Immunol. 2005, 175:1153-1160.
30. Pearl-Yafe M., Halperin D., Halevy A., Kalir H., Bielorai B., Fabian I. An oxidative mechanism of interferon induced priming of the Fas pathway in Fanconi anemia cells. Biochem. Pharmacol. 2003, 65:833-842.
31. Puttaparthi K., Elliott J.L. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp. Neurol. 2005, 196:441-451.
32. Reits E.A., Vos J.C., Grommé M., Neefjes J. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 2000, 404:774-778.
33. Reits E.A., Hodge J.W., Herberts C.A., Groothuis T.A., Chakraborty M., Wansley E.K., Camphausen K., Luiten R.M., de Ru A.H., Neijssen J., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 2006, 203:1259-1271.
34. Sasaki M., Ikeda H., Sato Y., Nakanuma Y. Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: A culture study. Free Radic. Res. 2008, 4:1-8.
35. Schubert U., Antón L.C., Gibbs J., Norbury C.C., Yewdell J.W., Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
36. Sijts A.J., Ruppert T., Rehermann B., Schmidt M., Koszinowski U., Kloetzel P.M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 2000, 191:503-514.
37. Strehl B., Joeris T., Rieger M., Visekruna A., Textoris-Taube K., Kaufmann S.H., Kloetzel P.M., Kuckelkorn U., Steinhoff U. Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cells. J. Immunol. 2006, 177:6238-6244.
38. Strehl B., Textoris-Taube K., Jäkel S., Voigt A., Henklein P., Steinhoff U., Kloetzel P.M., Kuckelkorn U. Antitopes define preferential proteasomal cleavage site usage. J. Biol. Chem. 2008, 283:17891-17897.
39. Szeto J., Kaniuk N.A., Canadien V., Nisman R., Mizushima N., Yoshimori T., Bazett-Jones D.P., Brumell J.H. ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2006, 2:189-199.
40. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K.B., Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem. 2000, 275:14336-14345.
41. Toes R.E., Nussbaum A.K., Degermann S., Schirle M., Emmerich N.P., Kraft M., Laplace C., Zwinderman A., Dick T.P., Müller J., et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 2001, 194:1-12.
42. Vabulas R.M., Hartl F.U. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 2005, 310:1960-1963.
43. Van Kaer L., Ashton-Rickardt P.G., Eichelberger M., Gaczynska M., Nagashima K., Rock K.L., Goldberg A.L., Doherty P.C., Tonegawa S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994, 1:533-541.
44. Voigt A., Jäkel S., Textoris-Taube K., Keller C., Drung I., Szalay G., Klingel K., Henklein P., Stangl K., Kloetzel P.M., Kuckelkorn U. Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. Amino Acids 2010, 39:243-255.
45. Watanabe Y., Suzuki O., Haruyama T., Akaike T. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J. Cell. Biochem. 2003, 89:244-253.
46. Yewdell J.W. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol. Rev. 2005, 207:8-18.
47. Yewdell J.W., Nicchitta C.V. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol. 2006, 27:368-373.
48. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990, 8:579-621.
49. Zheng P.Z., Wang K.K., Zhang Q.Y., Huang Q.H., Du Y.Z., Zhang Q.H., Xiao D.K., Shen S.H., Imbeaud S., Eveno E., et al. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 2005, 102:7653-7658.